New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 11, 2014
20:25 EDTAER, AER, LOJN, LOJN, RCPT, RCPT, TOUR, TOUR, OCIP, OCIP, CST, CST, FLO, FLO, KATE, KATE, VAL, VAL, TW, TW, CVG, CVGNotable companies reporting before tomorrow's open
Notable companies reporting before tomorrow's market open, with earnings consensus, include AerCap Holdings (AER), consensus 77c; Towers Watson (TW), consensus $1.25; Valspar (VAL), consensus $1.13; Kate Spade (KATE), consensus 0c; Flowers Foods (FLO), consensus 24c; CST Brands (CST), consensus 49c; OCI Partners (OCIP), consensus 64c; Tuniu (TOUR), consensus (21c); Receptos (RCPT), consensus (85c); LoJack (LOJN), one estimate 4c; Convergys (CVG), consensus 32c.
Sign up for a free trial to see the rest of the stories you've been missing.
October 30, 2014
10:02 EDTKATEOn The Fly: Analyst Initiation Summary
Subscribe for More Information
07:28 EDTLOJNLoJack sees FY14 revenue to be flat to slightly down from 2013 revenue
Subscribe for More Information
07:27 EDTLOJNLoJack reports Q3 EPS (45c), compared to 9c a year ago
Subscribe for More Information
07:26 EDTLOJNLoJack names Kenneth Dumas as CFO
Subscribe for More Information
06:00 EDTKATEKate Spade initiated with a Neutral at Mizuho
Target $28.
October 28, 2014
12:57 EDTRCPTOn The Fly: Midday Wrap
Subscribe for More Information
10:40 EDTRCPTHigh option volume stocks
Subscribe for More Information
09:20 EDTRCPTOn The Fly: Pre-market Movers
Subscribe for More Information
08:47 EDTRCPTReceptos price target raised to $125 from $72 at BMO Capital
Subscribe for More Information
08:13 EDTRCPTReceptos price target raised to $112 from $77 at Leerink
Subscribe for More Information
07:08 EDTRCPTReceptos price target raised to $153 from $80 at Wedbush
Wedbush raised Recptos' price target to $153 following strong Ulcerative Colitis results.
October 27, 2014
18:26 EDTRCPTOn The Fly: After Hours Movers
Subscribe for More Information
16:08 EDTRCPTReceptos up 32.7% after RPC1063 Phase 2 trial met primary, secondary endpoints
16:07 EDTRCPTReceptos reports RPC1063 Phase 2 trial met primary, all secondary endpoints
Subscribe for More Information
10:00 EDTFLOOn The Fly: Analyst Initiation Summary
Subscribe for More Information
09:09 EDTLOJNLoJack announces alliance with Trackunit A/S
LoJack announced a strategic alliance with leading international telematics provider Trackunit A/S. This agreement enables both companies to strengthen their positions as leading providers of commercial equipment telematics solutions. LoJack is launching LoJack Connect for Equipment.
07:19 EDTTWTowers Watson announced departure of Bryce Williams
Towers Watson disclosed Friday morning that Bryce Williams, a member of the company’s Exchange Solutions segment leadership team, announced that he will be leaving to take a CEO position with a start-up health care technology company. Williams’ last day at the company will be November 3. Towers Watson said it "believes it is well-positioned to capitalize on the opportunities for exchanges and looks forward to continuing its momentum in the Exchange Solutions segment."
06:31 EDTFLOFlowers Foods initiated with a Sell at Pivotal Research
Subscribe for More Information
October 20, 2014
13:10 EDTKATESteve Madden tumbles after providing preliminary Q3 results, FY14 outlook
Shares of shoe and accessory company Steve Madden (SHOO) are tumbling after the company announced preliminary third quarter results that were below analysts' consensus along with a reduction to its fiscal year 2014 outlook. WHAT'S NEW: Steve Madden announced that it is anticipating Q3 earnings per share to be approximately 61c-62c and net sales of $392M, below analysts' consensus estimates of 67c and $415.72M, respectively. The company noted that retail comparable store sales for the quarter are anticipated to be down 7.4%. Steve Madden also reduced its FY14 EPS outlook to $1.81-$1.86 from $2.00-$2.10, well below analysts' $2.02 consensus. The company lowered its net sales projection for the year, and now sees net sales up 1%-2% over fiscal year 2013 versus its previous net sales guidance for up 2%-4% over FY13. The new guidance factors in the recent acquisition of Dolce Vita and current expectations for remainder of the year. On August 14, Steve madden acquired Dolce Vita for $60.3M in cash and previously said the deal would be accretive to earnings in FY14 by 2c-3c and be "modestly accretive" in FY15. WHAT'S NOTABLE: Steve Madden's Chief Executive Officer Edward Rosenfeld said that the company's Q3 earnings were "disappointing" and were the result of weaker than expected retail segment performance. He believes that retail trends in the footwear space will continue to be difficult through the fourth quarter due to a lack of noteworthy fashion trends in the industry. The CEO said that the company's full-year guidance results from this pattern, along with a lowered reorder outlook in its wholesale segment. Rosenfeld is still confident, however, in the company's business model and believes that its acquisitions of Dolce Vita and its Mexican licensee will fuel the business forward over the long term. OTHERS TO WATCH: Competitors of Steve Madden include Michael Kors (KORS), Coach (COH), Kate Spade (KATE), and Vera Bradley. PRICE ACTION: During afternoon trading, shares of Steve Madden fell $2.62 or 8.2%, to $29.32. Over the last twelve months, the stock has fallen over 15%.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use